These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 3447879)

  • 21. Enzymuria determination in children treated with aminoglycosides drugs.
    Mohammadi-Karakani A; Asgharzadeh-Haghighi S; Ghazi-Khansari M; Seyed-Ebrahimi A; Ghasemi A; Jabari E
    Hum Exp Toxicol; 2008 Dec; 27(12):879-82. PubMed ID: 19273542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nephrotoxic potential of netilmicin as determined in a rat model.
    Luft FC
    Scand J Infect Dis Suppl; 1980; Suppl 23():82-90. PubMed ID: 6937971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The predictive value of urinary N-acetyl-beta-D-glucosaminidase in evaluating aminoglycoside nephrotoxicity.
    Guh JY; Su YH; Chen HJ; Tsai JH
    Taiwan Yi Xue Hui Za Zhi; 1985 Oct; 84(10):1099-107. PubMed ID: 3866825
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of muzolimine, a new diuretic, on experimental gentamicin nephrotoxicity.
    Toutain H; Olier B; Fillastre JP; Morin JP
    Nephrol Dial Transplant; 1987; 2(6):520-5. PubMed ID: 3126452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative nephrotoxicity of dibekacin and gentamicin in rats.
    Elliott WC; Parker RA; Houghton DC; Gilbert DN; Bennett WM
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):419-32. PubMed ID: 7330450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in aminoglycoside nephrotoxicity.
    Assadamongkol K; Tapaneya-Olarn W; Chatasingh S
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():42-6. PubMed ID: 2732646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists.
    Watanabe A; Nagai J; Adachi Y; Katsube T; Kitahara Y; Murakami T; Takano M
    J Control Release; 2004 Mar; 95(3):423-33. PubMed ID: 15023454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gentamicin and amikacin nephrotoxicity: comparative study in patients with initially normal renal function].
    Ballesteros J; Northland R; Wolff M
    Rev Med Chil; 1989 Jan; 117(1):10-7. PubMed ID: 2641618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity as a risk factor in drug-induced organ injury. IV. Increased gentamicin nephrotoxicity in the obese overfed rat.
    Corcoran GB; Salazar DE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):17-22. PubMed ID: 2913269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of methimazole and fish oil treatment on gentamicin nephrotoxicity in rats.
    el Daly ES
    J Pharm Belg; 1997; 52(4):149-56. PubMed ID: 9316341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglycoside nephrotoxicity: comparative assessment in critically ill patients.
    Plaut ME; Schentag JJ; Jusko WJ
    J Med; 1979; 10(4):257-66. PubMed ID: 294466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics].
    Gibey R; Dupond JL; Mallet H; Guerber F; Iehl-Robert M; Flausse-Parrot F; Becker M
    Nephrologie; 1986; 7(2):51-5. PubMed ID: 3736764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of urinary n-acetyl-beta-d-glucosaminidase activity in patients treated with aminoglycosides].
    Hirokawa N; Naruse T
    Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1041-53. PubMed ID: 7161951
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative study on renal accumulation of aminoglycoside antibiotics.
    Fujita K; Fujita HM
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):47-51. PubMed ID: 3988393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with type I juvenile diabetes mellitus and of patients treated with the aminoglycoside amikacin].
    Wiesmann U; Peheim E; Colombo JP
    Klin Wochenschr; 1989; 67 Suppl 17():40-3. PubMed ID: 2739356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 10. Clinical significance of urinary NAG activity in patients with kidney diseases, with special reference to nephrotic syndrome and antibiotic treatment].
    Ishimoto F; Shibazaki T; Murai S; Kodama K; Ohno I; Gomi H
    Rinsho Byori; 1983 Sep; Spec No 56():147-59. PubMed ID: 6663756
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxic effects on rabbit kidney cell cultures of a new aminoglycoside.
    Viano I; Bertelli AA; Dianzani C
    Drugs Exp Clin Res; 1987; 13(12):737-9. PubMed ID: 3447877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats.
    Ozer MK; Asci H; Oncu M; Yesilot S; Savran M; Bayram D; Cicek E
    Ren Fail; 2009; 31(2):134-9. PubMed ID: 19212910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.